{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:14:03Z","timestamp":1791994443704,"version":"4.4.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["63145"],"award-info":[{"award-number":["63145"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1044407"],"award-info":[{"award-number":["1044407"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001036","name":"Australian Rotary Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001036","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Rotary Club of Koo Wee Rup\u2014Lang Lang"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.nbd.2015.02.004","type":"journal-article","created":{"date-parts":[[2015,2,11]],"date-time":"2015-02-11T02:21:02Z","timestamp":1423621262000},"page":"87-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["A novel anticonvulsant mechanism via inhibition of complement receptor C5ar1 in murine epilepsy models"],"prefix":"10.1016","volume":"76","author":[{"given":"Melissa J.","family":"Benson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola K.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahil","family":"Talwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Hodson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph W.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trent M.","family":"Woodruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7448-0770","authenticated-orcid":false,"given":"Karin","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2015.02.004_bb0005","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.4049\/jimmunol.0903678","article-title":"Molecular intercommunication between the complement and coagulation systems","volume":"185","author":"Amara","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2015.02.004_bb0010","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.nbd.2007.01.015","article-title":"Complement activation in experimental and human temporal lobe epilepsy","volume":"26","author":"Aronica","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.02.004_bb0015","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1093\/brain\/awn271","article-title":"A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta","volume":"131","author":"Balosso","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2015.02.004_bb0020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.expneurol.2013.05.010","article-title":"The dual role of TNF-\u03b1 and its receptors in seizures","volume":"247","author":"Balosso","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.02.004_bb0025","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/0192-0561(94)90087-6","article-title":"Humoral and cellular immune parameters in untreated and phenytoin- or carbamazepine-treated epileptic patients","volume":"16","author":"Ba\u015faran","year":"1994","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.nbd.2015.02.004_bb0030","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1126\/science.1067859","article-title":"Control of synaptic strength by glial TNF\u03b1","volume":"295","author":"Beattle","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.nbd.2015.02.004_bb0035","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1111\/j.1460-9568.2003.02993.x","article-title":"Correlated stage- and subfield-associated hippocampal gene expression patterns in experimental and human temporal lobe epilepsy","volume":"18","author":"Becker","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2015.02.004_bb0040","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/89490","article-title":"CXCR4-activated astrocyte glutamate release via TNF\u03b1: amplification by microglia triggers neurotoxicity","volume":"4","author":"Bezzi","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2015.02.004_bb0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-4886(03)00086-4","article-title":"Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model","volume":"182","author":"Borges","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.02.004_bb0050","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/nm.1878","article-title":"A role for leukocyte-endothelial adhesion mechanisms in epilepsy","volume":"14","author":"Fabene","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2015.02.004_bb0055","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1021\/jm9806594","article-title":"Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a","volume":"42","author":"Finch","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.nbd.2015.02.004_bb0060","doi-asserted-by":"crossref","first-page":"11083","DOI":"10.1523\/JNEUROSCI.2766-06.2006","article-title":"Potential new antiepileptogenic targets indicated by microarray analysis in a rat model for temporal lobe epilepsy","volume":"26","author":"Gorter","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.02.004_bb0065","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1046\/j.1528-1157.2003.03603.x","article-title":"Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy","volume":"44","author":"Gouder","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2015.02.004_bb0070","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa061648","article-title":"The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"355","author":"Hillmen","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2015.02.004_bb0075","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s11306-008-0135-1","article-title":"An approach for the development and selection of chromatographic methods for high-throughput metabolomic screening of urine by ultra pressure LC\u2013ESI-ToF-MS","volume":"5","author":"Hodson","year":"2009","journal-title":"Metabolomics"},{"key":"10.1016\/j.nbd.2015.02.004_bb0080","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.molimm.2007.10.037","article-title":"Disruption of the C5a receptor gene increases resistance to acute gram-negative bacteremia and endotoxic shock: opposing roles of C3a and C5a","volume":"45","author":"Hollmann","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.nbd.2015.02.004_bb0085","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000026433","article-title":"Cytokine effects on glutamate uptake by human astrocytes","volume":"7","author":"Hu","year":"2000","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.nbd.2015.02.004_bb0090","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0306-4522(96)00107-8","article-title":"Complement factor C5a and epidermal growth factor trigger the activation of outward potassium currents in cultured murine microglia","volume":"73","author":"Ilschner","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2015.02.004_bb0095","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1471-4159.2011.07490.x","article-title":"C5a\/CD88 signaling alters blood\u2013brain barrier integrity in lupus through nuclear factor-kappaB","volume":"119","author":"Jacob","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2015.02.004_bb0100","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/brain\/awl001","article-title":"Large-scale expression study of human mesial temporal lobe epilepsy: evidence for dysregulation of the neurotransmission and complement systems in the entorhinal cortex","volume":"129","author":"Jamali","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2015.02.004_bb0105","doi-asserted-by":"crossref","first-page":"e12740","DOI":"10.1371\/journal.pone.0012740","article-title":"Functional variant in complement C3 gene promoter and genetic susceptibility to temporal lobe epilepsy and febrile seizures","volume":"5","author":"Jamali","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nbd.2015.02.004_bb0110","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1074-7613(02)00275-3","article-title":"Arthritis critically dependent on innate immune system players","volume":"16","author":"Ji","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.nbd.2015.02.004_bb0115","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/j.1538-7836.2006.02046.x","article-title":"The complement component C5a induces the expression of plasminogen activator inhibitor-1 in human macrophages via NF-\u03baB activation","volume":"4","author":"Kastl","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.nbd.2015.02.004_bb0120","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00429-013-0528-4","article-title":"MRI changes and complement activation correlate with epileptogenicity in a mouse model of temporal lobe epilepsy","volume":"219","author":"Kharatishvili","year":"2014","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.nbd.2015.02.004_bb0125","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1227\/01.NEU.0000335079.70222.8D","article-title":"Protective effect of C5a receptor inhibition after murine reperfused stroke","volume":"63","author":"Kim","year":"2008","journal-title":"Neurosurgery"},{"key":"10.1016\/j.nbd.2015.02.004_bb0130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0014-2999(98)00410-5","article-title":"Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy","volume":"353","author":"Klitgaard","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2015.02.004_bb0135","first-page":"529","article-title":"Drug evaluation: the C5a receptor antagonist PMX-53","volume":"8","author":"Koehl","year":"2006","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.nbd.2015.02.004_bb0140","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMra1004418","article-title":"Drug-resistant epilepsy","volume":"365","author":"Kwan","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2015.02.004_bb0145","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1095\/biolreprod.111.098475","article-title":"Complement C5a regulates prolabor mediators in human placenta","volume":"86","author":"Lappas","year":"2012","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.nbd.2015.02.004_bb0150","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nbd.2014.02.008","article-title":"Complement C5a is detrimental to histological and functional locomotor recovery after spinal cord injury in mice","volume":"66","author":"Li","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.02.004_bb0155","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1124\/mol.65.4.868","article-title":"Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activity","volume":"65","author":"March","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2015.02.004_bb0160","doi-asserted-by":"crossref","first-page":"e18200","DOI":"10.1371\/journal.pone.0018200","article-title":"Efficacy of anti-inflammatory therapy in a model of acute seizures and in a population of pediatric drug resistant epileptics","volume":"6","author":"Marchi","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nbd.2015.02.004_bb0165","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s13311-011-0039-z","article-title":"Interleukin-1\u03b2 biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice","volume":"8","author":"Maroso","year":"2011","journal-title":"Neurotherapeutics"},{"issue":"8","key":"10.1016\/j.nbd.2015.02.004_bb0170","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/glia.22680","article-title":"Fosb gene products contribute to excitotoxic microglial activation by regulating the expression of complement C5a receptors in microglia","volume":"62","author":"Nomaru","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2015.02.004_bb0175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0165-5728(00)00291-5","article-title":"The C5a complement activation peptide increases IL-1\u03b2 and IL-6 release from amyloid-\u03b2 primed human monocytes: implications for Alzheimer's disease","volume":"109","author":"O'Barr","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2015.02.004_bb0180","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0306-4522(98)00372-8","article-title":"Expression of C5a receptor in mouse brain: role in signal transduction and neurodegeneration","volume":"88","author":"Osaka","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2015.02.004_bb0185","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1096\/fj.11-202382","article-title":"Generation of complement component C5a by ischemic neurons promotes neuronal apoptosis","volume":"26","author":"Pavlovski","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2015.02.004_bb0190","doi-asserted-by":"crossref","first-page":"17151","DOI":"10.1073\/pnas.0806682105","article-title":"Microglial activation and TNF\u03b1 production mediate altered CNS excitability following peripheral inflammation","volume":"105","author":"Riazi","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2015.02.004_bb0195","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.eplepsyres.2008.05.001","article-title":"Anticonvulsant profile of a balanced ketogenic diet in acute mouse seizure models","volume":"81","author":"Samala","year":"2008","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nbd.2015.02.004_bb0200","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1039\/b604498k","article-title":"A pragmatic and readily implemented quality control strategy for HPLC\u2013MS and GC\u2013MS-based metabonomic analysis","volume":"131","author":"Sangster","year":"2006","journal-title":"Analyst"},{"key":"10.1016\/j.nbd.2015.02.004_bb0205","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0006-8993(00)02513-0","article-title":"Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration","volume":"874","author":"Schmued","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2015.02.004_bb0210","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1074\/jbc.M609178200","article-title":"The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding","volume":"282","author":"Scola","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2015.02.004_bb0215","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jneuroim.2004.06.003","article-title":"Complement C3 and C5 play critical roles in traumatic brain cryoinjury: blocking effects on neutrophil extravasation by C5a receptor antagonist","volume":"155","author":"Sewell","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2015.02.004_bb0220","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/jcbfm.2013.54","article-title":"Brain mitochondrial metabolic dysfunction and glutamate level reduction in the pilocarpine model of temporal lobe epilepsy in mice","volume":"33","author":"Smeland","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2015.02.004_bb0225","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1523\/JNEUROSCI.4486-04.2005","article-title":"Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-\u03b1","volume":"25","author":"Stellwagen","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.02.004_bb0230","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/sj.bjp.0704417","article-title":"Inhibition of immune-complex mediated dermal inflammation in rats following either oral or topical administration of a small molecule C5a receptor antagonist","volume":"134","author":"Strachan","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2015.02.004_bb0235","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.eplepsyres.2011.12.013","article-title":"Triheptanoin in acute mouse seizure models","volume":"99","author":"Thomas","year":"2012","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nbd.2015.02.004_bb0240","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1471-4159.2006.03872.x","article-title":"Interleukin-1-induced neurotoxicity is mediated by glia and requires caspase activation and free radical release","volume":"98","author":"Thornton","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2015.02.004_bb0245","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/brain\/awl318","article-title":"Blood\u2013brain barrier leakage may lead to progression of temporal lobe epilepsy","volume":"130","author":"Van Vliet","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2015.02.004_bb0250","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/rheumatology\/kem222","article-title":"Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammation","volume":"46","author":"Vergunst","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.nbd.2015.02.004_bb0265","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/j.1528-1167.2005.00298.x","article-title":"Brain inflammation in epilepsy: experimental and clinical evidence","volume":"46","author":"Vezzani","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2015.02.004_bb0255","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1523\/JNEUROSCI.19-12-05054.1999","article-title":"Interleukin-1\u03b2 immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures","volume":"19","author":"Vezzani","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.02.004_bb0270","doi-asserted-by":"crossref","first-page":"11534","DOI":"10.1073\/pnas.190206797","article-title":"Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice","volume":"97","author":"Vezzani","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2015.02.004_bb0260","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","article-title":"The role of inflammation in epilepsy","volume":"7","author":"Vezzani","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2015.02.004_bb0275","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1471-4159.2000.740457.x","article-title":"\u201cInflammatory\u201d cytokines","volume":"74","author":"Vitkovic","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2015.02.004_bb0280","doi-asserted-by":"crossref","first-page":"8692","DOI":"10.1523\/JNEUROSCI.23-25-08692.2003","article-title":"Interleukin-1\u03b2 enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases","volume":"23","author":"Viviani","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.02.004_bb0285","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/epi.12296","article-title":"Issues related to development of new antiseizure treatments","volume":"54","author":"Wilcox","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2015.02.004_bb0290","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.nbd.2010.07.017","article-title":"Anticonvulsant effects of a triheptanoin diet in two mouse chronic seizure models","volume":"40","author":"Willis","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.02.004_bb0295","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1021\/jm9800651","article-title":"Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a","volume":"41","author":"Wong","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.nbd.2015.02.004_bb0315","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1124\/jpet.105.086835","article-title":"Increased potency of a novel complement factor 5a receptor antagonist in a rat model of inflammatory bowel disease","volume":"314","author":"Woodruff","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2015.02.004_bb0310","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1096\/fj.05-5814com","article-title":"Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration","volume":"20","author":"Woodruff","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2015.02.004_bb0305","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.4049\/jimmunol.181.12.8727","article-title":"The complement factor C5a contributes to pathology in a rat model of amyotrophic lateral sclerosis","volume":"181","author":"Woodruff","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2015.02.004_bb0300","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12017-009-8085-y","article-title":"The role of the complement system and the activation fragment C5a in the central nervous system","volume":"12","author":"Woodruff","year":"2010","journal-title":"Neruomol. Med."},{"key":"10.1016\/j.nbd.2015.02.004_bb0320","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1523\/JNEUROSCI.23-03-00955.2003","article-title":"Formation of complement membrane attack complex in mammalian cerebral cortex evokes seizures and neurodegeneration","volume":"23","author":"Xiong","year":"2003","journal-title":"J. Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115000248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115000248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T04:57:39Z","timestamp":1537851459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996115000248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":64,"alternative-id":["S0969996115000248"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2015.02.004","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel anticonvulsant mechanism via inhibition of complement receptor C5ar1 in murine epilepsy models","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2015.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}